ERYTHROMYCIN
C14312
http://purl.bioontology.org/ontology/NDFRT/C14312
Drug Hypersensitivity
Liver Diseases
Astemizole
Cisapride
Terfenadine
Pimozide
Erythromycin
Protein Synthesis Inhibitors
Decreased Protein Synthesis
Ingredient
Streptococcal Infections
Mycoplasma Infections
Erythrasma
Gastroenteritis
Campylobacter Infections
Legionnaires' Disease
Chancroid
Chlamydia Infections
Staphylococcal Infections
Gonorrhea
Urethritis
Eye Infections, Bacterial
Syphilis
Acne Vulgaris
Whooping Cough
NDF_KIND
N0000145975
E [Preparations]
ERYTHROMYCIN 250MG TAB,EC
ERYTHROMYCIN 250MG TAB
ERYTHROMYCIN 250MG CAP,SA
ERYTHROMYCIN 250MG CAP,EC
ERYTHROMYCIN 250MG CAP
ERYTHROMYCIN PWDR
ERYTHROMYCIN 2% SOLN,TOP
ERYTHROMYCIN 2% PLEDGET SOLN,TOP
ERYTHROMYCIN 2% PAD,TOP
ERYTHROMYCIN 2% OINT,TOP
ERYTHROMYCIN 2% GEL,TOP
ERYTHROMYCIN 500MG TAB,SA
BENZOYL PEROXIDE 5%/ERYTHROMYCIN 3% GEL,TOP
ERYTHROMYCIN 125MG/5ML SUSP
ERYTHROMYCIN 125MG CAP,EC
ERYTHROMYCIN 500MG TAB,EC
ERYTHROMYCIN 500MG TAB
ERYTHROMYCIN 1.5% SOLN,TOP
ERYTHROMYCIN 0.5% OINT,OPH,PKG,1GM
ERYTHROMYCIN 333MG TAB,SA
ERYTHROMYCIN 333MG TAB,EC
ERYTHROMYCIN 0.5% OINT,OPH
ERYTHROMYCIN 333MG TAB
4053
Organic Chemical
Antibiotic
C0014806
True
4017594